Xoma reported $79.74M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US USD 213.12M 38.31M
Agios Pharmaceuticals AGIO:US USD 832.77M 47.84M
Ardelyx ARDX:US USD 153.6M 33.73M
Biomarin Pharmaceutical BMRN:US USD 2.75B 68.76M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Celldex Therapeutics CLDX:US USD 317.69M 16.91M
Chimerix CMRX:US USD 228.14M 62.98M
Curis CRIS:US USD 92.12M 13.6M
Emergent Biosolutions EBS:US USD 1.21B 92.2M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Macrogenics MGNX:US USD 222.18M 74.37M
Novartis NOVN:VX USD 36.91B 44M
Novartis NVS:US USD 36.91B 44M
Prothena PRTA:US USD 719.1M 194.54M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M
YTE INCY:US USD 4.09B 271.74M